<DOC>
	<DOCNO>NCT00556257</DOCNO>
	<brief_summary>A new immunosuppressive drug base inhibition important enzyme immune system call JAK3 , develop Pfizer prevent transplant rejection . In research study , JAK3 inhibitor cyclosporine give new kidney transplant patient 12 month addition standard transplant medication prednisone .</brief_summary>
	<brief_title>Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Recipient first time kidney transplant Between age 18 70 year , inclusive Recipient nonkidney transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Immunosuppression , JAK3 inhibitor , kidney transplantation</keyword>
</DOC>